5 years out
2031 · 2031
Late-NISQ to early-utility transition. First documented commercial quantum advantage in chemistry. Quantum sensors widely deployed in defense. PQC migration well underway.
Technical state
100-logical-qubit demonstrations routine. Best systems at ~1,000 physical qubits with 99.99% 2Q fidelity. First useful chemistry simulations — small molecules, catalyst optimization. RSA still safe but federal mandates accelerating. Fault tolerance demonstrated at small scale; useful FTQC still 3–5 years away.
How this affects your life
Mostly invisible. You'll get a few emails from your bank/government about post-quantum migration. Some of your medicines will have been accelerated through quantum-aided design pipelines. Your phone's encryption is already quantum-safe (Apple did this in 2024). Your cloud bills include a "quantum compute" line item if you're in pharma, materials, or finance.
Upside scenarios
💊Drug discovery accelerated
A few major pharma companies announce drug candidates whose early-stage simulations were quantum-accelerated. AstraZeneca + IonQ, Roche + Quantinuum, BMS + IBM all have programs in clinical trials.
🔋Better batteries hit the market
Quantum-discovered cathode materials begin appearing in commercial Li-ion and solid-state batteries. EV charging times drop ~20%, costs follow. Grid-storage chemistry gets meaningful boost.
🛰️GPS-denied navigation goes mainstream
Quantum sensors deployed across naval and aerial defense platforms. Civilian aviation adopts quantum-inertial nav as GPS backup. Atomic-clock-based timing replaces some GPS dependencies.
💰Wall Street gets a real quantum advantage
Multiple banks publish papers with documented commercial advantage on derivatives pricing and portfolio optimization (following HSBC's 2025 bond paper). Goldman, JPM, Morgan Stanley each have production quantum pipelines.
Downside risks
⚠️Harvest-now-decrypt-later payoff begins
If early FTQC arrives faster than expected, adversaries decrypt 2020–2024 stockpiles of encrypted intelligence. Likely smaller-scale incidents at first — embarrassing leaks rather than catastrophic ones.
📉Quantum capital bubble compresses
Public pure-plays that don't produce real revenue lose 50–80% of valuation. Most retail-favorite quantum stocks see significant write-downs. Capital rotates toward 2–3 surviving leaders.
🤖Quantum-AI hype continues unproductively
Companies attach "quantum" to AI marketing without demonstrated advantage. Consumer products bearing "quantum-enhanced AI" labels mostly aren't.
Signals that confirm we're on track
- →First public earnings call where a public company attributes >$50M revenue to quantum-computing-driven product
- →A drug candidate enters Phase 2 trials with documented quantum-aided discovery in the FDA filing
- →First nation-state cyber incident publicly attributed to quantum decryption
- →Stage C DARPA QBI survivors announced (Q4 2026 → Stage C completes 2028–2030)